- Description
-
Détails
Thermogenic : un composé de 5 éléments actifs
Le Thermogenic est composé de 5 actifs naturels :
du CLA (acide linoléique conjugé),
du Citrus Aurantium (oranger bigaradier),
du Chrome (qui régule le taux de glucose dans le sang),
du Zinc (qui aide au métabolisme des glucides),
de l'huile de son de riz
La législation européenne ne nous autorisant pas à communiquer sur ces actifs naturels, nous vous conseillons de vous renseigner dans la littérature scientifique si vous souhaitez en savoir davantage, et à vous faire votre propre avis.
Bibliographie
Source : passeportsante.net
1. Conjugated linoleic acids: why the discrepancy between animal and human studies? Plourde M, Jew S, et al. Nutr Rev. 2008 Jul; 66(7):415-21. Review.
2. Conjugated linoleic acid (CLA) and obesity. Silveira MB, Carraro R, et al. Public Health Nutr. 2007 Oct; 10(10A):1181-6. Review.
3. Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Whigham LD, Watras AC, Schoeller DA. Am J Clin Nutr. 2007; 85:1203-1211.
4. Conjugated linoleic acids. Campbell B, Kreider RB. Curr Sports Med Rep. 2008 Jul-Aug; 7(4):237-41. Review.
5. Conjugated linoleic acid (CLA): effect modulation of body composition and lipid profile. Baddini Feitoza A, Fernandes Pereira A, et al. Nutr Hosp. 2009 Jul-Aug; 24(4):422-8. Review.
6. A meta-analysis of the effects of conjugated linoleic acid on fat-free mass in humans. Schoeller DA, Watras AC, Whigham LD. Appl Physiol Nutr Metab. 2009 Oct; 34(5):975-8.
7. Effects of milk supplementation with conjugated linoleic acid (isomers cis-9, trans-11 and trans-10, cis-12) on body composition and metabolic syndrome components. Laso N, Brugue E, et al. Br J Nutr. 2007 Oct; 98(4):860-7.
8. Effect of a conjugated linoleic acid and omega-3 fatty acid mixture on body composition and adiponectin. Sneddon AA, Tsofliou F, et al. Obesity (Silver Spring). 2008 May; 16(5):1019-24.11.
9. Kelly GS. Conjugated linoleic acid: a review.Altern Med Rev 2001 Aug; 6(4):367-82. Texte intégral : https://www.thorne.com
10. Ryder JW, Portocarrero CP, Song XM, et al. Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression.Diabetes 2001 May; 50(5):1149-57.
11. Zambell KL, Horn WF, Keim NL. Conjugated linoleic acid supplementation in humans: effects on fatty acid and glycerol kinetics.Lipids2001 Aug; 36(8):767-72.
12. Smedman A, Vessby B. Conjugated linoleic acid supplementation in humans--metabolic effects.Lipids 2001 Aug; 36(8):773-81.Review.
13. Noone EJ, Roche HM, et al. The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects.Br J Nutr 2002 Sep; 88(3):243-51.
14. The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese. Syvertsen C, Halse J, et al. Int J Obes (Lond). 2007 Jul; 31(7):1148-54.
15. Moloney F, Yeow TP, et al. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2004 Oct; 80(4):887-95.
16. Effects of conjugated linoleic acid plus n-3 polyunsaturated fatty acids on insulin secretion and estimated insulin sensitivity in men. Ahrén B, Mari A, et al. Eur J Clin Nutr. 2009 Jun; 63(6):778-86.
17. Riserus U, Basu S, et al. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation. 2002 Oct 8; 106(15):1925-9.
18. Riserus U, Arner P, et al. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care. 2002 Sep; 25(9):1516-21.
19. Riserus U, Vessby B, et al. Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. Diabetologia. 2004 Jun; 47(6):1016-9.
20. Riserus U, Vessby B, et al. Effects of cis-9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr. 2004 Aug; 80(2):279-83.
21. Conjugated linoleic acid combined with creatine monohydrate and whey protein supplementation during strength training. Cornish SM, Candow DG, et al. Int J Sport Nutr Exerc Metab. 2009 Feb; 19(1):79-96.
22. The potential benefits of creatine and conjugated linoleic acid as adjuncts to resistance training in older adults. Tarnopolsky MA, Safdar A. Appl Physiol Nutr Metab. 2008 Feb; 33(1):213-27. Review.
23. Desroches S, Chouinard PY, et al. Lack of effect of dietary conjugated linoleic acids naturally incorporated into butter on the lipid profile and body composition of overweight and obese men. Am J Clin Nutr. 2005 Aug; 82(2):309-19.
24. Gaullier JM, Halse J, et al. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans.Am J Clin Nutr. 2004 Jun; 79(6):1118-25. Texte intégral : https://www.ajcn.org
25. Dietary supplementation with cis-9,trans-11 conjugated linoleic acid and aortic stiffness in overweight and obese adults. Sluijs I, Plantinga Y, et al. Am J Clin Nutr. 2010 Jan; 91(1):175-83.
26. O’Shea M, Bassaganya-Riera J, Mohede IC. Immunomodulatory properties of conjugated linoleic acid. Am J Clin Nutr. 2004 Jun; 79(6 Suppl):1199S-1206S. Texte integral : https://www.ajcn.org
27. Kelley DS, Erickson KL. Modulation of body composition and immune cell functions by conjugated linoleic acid in humans and animal models: benefits vs. risks. Lipids. 2003 Apr; 38(4):377-86. Review.
28. Albers R, van der Wielen RP, et al. Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men. Eur J Clin Nutr. 2003 Apr; 57(4):595-603.
29. Nugent AP, Roche HM, et al. The effects of conjugated linoleic acid supplementation on immune function in healthy volunteers. Eur J Clin Nutr. 2005 Jun; 59(6):742-50.
30. Song HJ, Grant I, et al. Effect of CLA supplementation on immune function in young healthy volunteers. Eur J Clin Nutr. 2005 Apr; 59(4):508-17.
31. Tricon S, Burdge GC, et al. Effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on immune cell function in healthy humans. Am J Clin Nutr. 2004 Dec; 80(6):1626-33. Texte intégral : http:https://www.ajcn.org
32. Immunological and metabolic effects of cis-9, trans-11-conjugated linoleic acid in subjects with birch pollen allergy. Turpeinen AM, Ylonen N, et al.Br J Nutr. 2008 Jul;100(1):112-9.29.
33. Masters N, McGuire MA, et al. Maternal supplementation with CLA decreases milk fat in humans.Lipids 2002 Feb; 37(2):133-8.
34. Taylor JS, Williams SR, et al. Conjugated linoleic acid impairs endothelial function. Arterioscler Thromb Vasc Biol. 2006 Feb; 26(2):307-1.
35. ConsumerLab.com. Product Review: CLA (Conjugated Linoleic Acid) for Slimming, janvier 2010 [Consulté le 27 février 2010] https://www.consumerlab.com
1. Haaz S, Fontaine KR, et al. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update. Obes Rev. 2006 Feb;7(1):79-88.
2. Bent S, Padula A, Neuhaus J. Safety and efficacy of citrus aurantium for weight loss. Am J Cardiol. 2004 Nov 15;94(10):1359-61. Review.
3. Fugh-Bergman A, Myers A. Citrus aurantium, an Ingredient of Dietary Supplements Marketed for Weight Loss : Current Status of Clinical and Basic Research, Experimental Biology and Medicine. Exp Biol Med (Maywood). 2004 Sep;229(8):698-704. Texte intégral : https://www.ebmonline.org
4. Potential applications for alternative medicine to treat obesity in an aging population. Cherniack EP.Altern Med Rev. 2008 Mar;13(1):34-42. Review. Texte intégral : https://www.thorne.com
5. Hedrei P, Gougeon R. Thermogenic effect of beta sympathicomimetic compounds extracted from Citrus aurantium. McGill Nutrition and Food Science Center, Royal Victoria Hospital : Canada, 1997 (report). Rapport cité et résumé dans la synthèse de la note 1.
6. Pathak B, Gougeon R. Thermic effect of Citrus aurantium in obese subjects. Current Therapeutic Res 1999; 60: 145–151. Étude citée et résumée dans la synthèse de la note 1.
7. Sale C, Harris RC, et al. Metabolic and physiological effects of ingesting extracts of bitter orange, green tea and guarana at rest and during treadmill walking in overweight males. Int J Obes (Lond). 2006 May;30(5):764-73.
8. Effects of limonene and essential oil from Citrus aurantium on gastric mucosa: role of prostaglandins and gastric mucus secretion. Moraes TM, Kushima H, et al. Chem Biol Interact. 2009 Aug 14;180(3):499-505.
9. Essential oils and anxiolytic aromatherapy. Setzer WN. Nat Prod Commun. 2009 Sep;4(9):1305-16.
10. Behavioral effects of essential oil of Citrus aurantium L. inhalation in rats. Leite MP, Fassin J,et al. Brazilian Journal of Pharmacognosy. Dez. 2008 18 (Supl.), 661-666. Texte intégral : https://www.scielo.br
11. Effects of the essential oil from Citrus aurantium L. in experimental anxiety models in mice. Pultrini Ade M, Galindo LA, Costa M. Life Sci. 2006 Mar 6;78(15):1720-5.
12. Effects of Juniper and Bergamot Essential Oils on Anxiety and Methamphetamine Reward in Mice. Tu CH. M.S. Thesis, National Cheng Kung University, Taiwan, ROC, 2003.
13. Anxiolytic and sedative effects of extracts and essential oil from Citrus aurantium L. (a) Carvalho-Frietas MIR, Costa M. Biol Pharm Bull. 2002 Dec;25(12):1629-33. Texte intégral : https://www.jstage.jst.go.jp
14. Ramadan W, Mourad B, et al. Oil of bitter orange: new topical antifungal agent. Int J Dermatol. 1996 Jun;35(6):448-9.
15. Ischemic colitis associated with use of a bitter orange-containing dietary weight-loss supplement. Sultan S, Spector J, Mitchell RM. Mayo Clin Proc. 2006 Dec;81(12):1630-1. Texte intégral : https://www.mayoclinicproceedings.com
16. Variant angina associated with bitter orange in a dietary supplement. Gange CA, Madias C, et al.Mayo Clin Proc. 2006 Apr;81(4):545-8. Texte intégral : https://www.mayoclinicproceedings.com
17. Santé Canada. Orange amère ou synéphrine : mise à jour sur les effets indésirables cardiovasculaires. Bulletin canadien des effets indésirables, Volume 17 - numéro 2 - avril 2007. [Consulté le 19 novembre 2009] https://www.hc-sc.gc.ca
18. Santé Canada. Santé Canada met en garde les Canadiens contre l'utilisation du « Thermonex », 28 mai 2004 [Consulté le 23 octobre 2009] https://www.hc-sc.gc.ca
19. Bouchard NC, Howland MA, et al. Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine.Mayo Clin Proc. 2005;80:541-5. Texte intégral : https://www.mayoclinicproceedings.com
20. Coronary spasm and thrombosis in a bodybuilder using a nutritional supplement containing synephrine, octopamine, tyramine and caffeine. Smedema JP, Müller GJ. S Afr Med J. 2008 May;98(5):372-3. No abstract available. Résumé : https://www.sabinet.co.za
21. Bui LT, Nguyen DT, Ambrose PJ. Blood pressure and heart rate effects following a single dose of bitter orange. Ann Pharmacother. 2006 Jan;40(1):53-7.
22. Min B, Cios D, et al. Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects. Pharmacotherapy. 2005 Dec;25(12):1719-24.
23. Haller CA, Benowitz NL, Jacob P 3rd. Hemodynamic effects of ephedra-free weight-loss supplements in humans. Am J Med. 2005 Sep;118(9):998-1003.
24. Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions. Haller CA, Duan M et al. Br J Clin Pharmacol. 2008 Jun;65(6):833-40.
25. Malhotra S, Bailey DG, et al. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins. Clin Pharmacol Ther 2001;69:14-23.
26. Edwards DJ, Fitzsimmons ME, et al. 6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin Pharmacol Ther. 1999 Mar;65(3):237-44.
27. Mitchell Dave. Synephrine, a bitter pill to swallow, 2008. [Consulté le 23 octobre 2009] https://www.davesworkout.com
1. MH Lai, YT Chen, YY Chen, et al., Effects of rice bran oil on the blood lipids profiles and insulin resistance in type 2 diabetes patients, J Clin Biochem Nutr, 2012
2. TW Chou, CY Ma, HH Cheng, et al., A Rice Bran Oil Diet Improves Lipid Abnormalities and Suppress Hyperinsulemic Responses in Rats with Streptozotocin/Nicotinamide-Induced Type 2 Diabetes, J Clin Biochem Nutr, 2009